ORHub (ORHB) Appoints New Chief Operating Officer to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
99
ORHub (ORHB) Appoints New Chief Operating Officer to Facilitate Growth Strategies

NEWPORT BEACH, CA--(Marketwired - May 2, 2017) - In conjunction with its plans to scale corporate operations, ORHub, Inc. ( OTC : ORHB ), a cloud-based health care SaaS company focused on transforming the business of surgery, today announces the appointment of Dr. Cyrus Olsen, Ph.D. as the Company's new chief operating officer.

As previously announced, ORHub has successfully monitored and collected valuable data from more than 500 surgery cases, an achievement that positions the Company to scale its operations. In light of this anticipated growth, ORHub has hired Dr. Olsen. Dr. Olsen has been in an advisory role since the inception of ORHub, and he has worked extensively with Microsoft and other health care organizations. As an expert in linking strategy to execution, Dr. Olsen brings over 25 years of experience in IT, operations, organizational infrastructure, marketing and finance to ORHub as it prepares to scale out its platform. A 1991 graduate of Northwestern University's J.L. Kellogg Graduate School of Management's Ph.D. program under Stephen Shortell [former A.C. Buehler Distinguished Professor of Health Services Management], Dr. Olsen has helped Fortune 500 and smaller companies link strategic thinking and planning to execution at both a conceptual and implementation level, utilizing IT infrastructure and cloud computing as strategic tools.

A veteran of building business IT solutions, SaaS, PaaS and IaaS cloud infrastructures, Dr. Olsen's background includes six years as an OR and ER tech, designing value-based ER strategies for HMA health care group, and restructuring the support and network infrastructure of an SaaS patient referral and scheduling company. He worked with Microsoft in its Amalga team as an external consultant and has deep experience in building analytic BI platforms for companies like Microsoft and Juniper Networks, supporting internal business operations. Dr. Olsen brings experience in health care, process engineering, time-driven activity-based cost [TDABC] modeling, analytics, and organizational infrastructure implementation to drive scaling out ORHub's organization in support of deployment roadmaps.

"Dr. Olsen will be responsible for creating the execution roadmap and scaling the organization. His expertise in building software platforms and organizational services will add significant depth to the company and position us for execution excellence as we scale out. His past work with CTO Wesley Mitchell, and his early participation in ORHub, make the timing right for us to have him join us full time. The integration of technical vision with execution, and organizational vision, analytics, and execution is a real force multiplier for us," says ORHub CEO Colt Melby.

Dr. Olsen has worked across a diverse line of industries that includes health care, software, aerospace, telecommunications and manufacturing. He began his business career in industrial engineering and completed a doctorate in organizational behavior. During his doctoral work, he was actively working with neural networks and AI design in support of decision making. He also taught strategy and information systems at the university level for both graduate and undergraduate programs before starting his own IT infrastructure company. That entity was acquired and resold in the late 1990s after building early personalization and predictive choice prototypes for web services. Since that time, Dr. Olsen has led global business and IT projects, consulted on cloud service infrastructures, built analytics platforms, and linked strategy to execution as a technical business focus for decision making. 

"ORHub has done a tremendous job of identifying the data flows as a service chain across departments for perioperative suites and hospital value creation. This concept of data chaining provides analytics that are currently unavailable to hospitals. With the increasing numbers of surgeries we are now seeing, we can create the data sets to condition our analytics. The business value for decision making and implementation is that ORHub is a lightweight data control plane that fits seamlessly into existing hospital environments, is easy to deploy, is HIPAA compliant, and provides a very fast ROI for our customers. I am excited to be a part of an effort to address the business and service needs of the health care industry," says Dr. Olsen.

About ORHub, Inc.

ORHub is a cloud-based software platform focused on delivering value-based medicine in surgical care. The company enables all parties involved in surgical care to work together to organize, deliver, measure and reimburse in a single uniform process. This allows for significant decreases in cost and improvement in outcomes by eliminating non value-added activities, duplication of effort, and errors and omissions that result from siloed processes and poor handoffs from one part of the care process to another.

The need for ORHub is clear. Health care comprises more than 17% of US GDP at over $3 trillion per year. With costs rising every year due to an aging population and more expensive treatments, providers are under severe pressure to become more efficient and reduce costs from payers who are aggressively reducing reimbursements and finally moving away from fee-for-service and toward performance-based reimbursement. ORHub enables providers to thrive in this new environment by addressing the single largest segment of health care, which is surgical care. ORHub overlays numerous legacy systems with a 360 degree system that is a lightweight data network focused on tracking cost from diagnosis to discharge centered on treating a patient for a specific condition. ORHub has offices in Phoenix, Arizona; Newport Beach, California; and Bellevue, Washington.

For more information, visit www.orhub.com .

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Although the Company believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, it can give no assurances that its expectations will be attained. Such statements are inherently uncertain, and actual results and activities may differ materially from those estimated or projected. Certain factors that can affect the Company's ability to achieve its anticipated results include, among others, uncertainties inherent in the development of a new software product business.

Communications Contact: NetworkNewsWire (NNW) New York, New York www.NetworkNewsWire.com 212.418.1217 Office Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 186

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 206

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 201

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 183

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 0

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 84

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 166

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 203

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading

Top 5 Most Recently Viewed Articles

Bertucci Investment Group: Earning Five-Star Results from Clients

Updated Category News Views 160

Bertucci Investment Group: Celebrating Success Bertucci Investment Group, known for facilitating smooth property sales for cash, is excited to share its significant achievement of earning consistent five-star reviews on Google. This milestone highlights the company’s dedication to providing an efficient and trustworthy service for homeowners. A Commitment to Excellence...

Continue Reading
Understanding Current Mortgage Rates and Refinancing Options

Updated Category News Views 98

Current Mortgage Rate Trends The 30-year mortgage rate has recently fallen to 5.93%, indicating a positive shift in the market compared to previous rates. This change is significant, as refinancing rates have also decreased substantially. These developments present opportunities for both new homebuyers and those looking to refinance their current loans. Current Mortgage...

Continue Reading
Market Reactions: Bitcoin Struggles Amid Rising Geopolitical Tensions

Updated Category News Views 55

Market Insights on Bitcoin's Challenges The narrative that Bitcoin operates as a safe haven during times of geopolitical tension has recently faced significant scrutiny. The leading cryptocurrency experienced a sharp decline, dropping below $62,000, amidst fears of escalating conflict in the Middle East. Bitcoin's Downturn As the situation escalated with reports of Iran's...

Continue Reading
Karsan's Autonomous Bus Debuts at Efteling Park

Updated Category News Views 100

A Leap Towards Autonomous Mobility What we have here is Karsan breaking new ground again. They've rolled out their Autonomous e-ATAK at Efteling, the famous theme park in the Netherlands. And that's not just any park—it's a place teeming with tourists, a hotspot demanding efficient transport. Yet, these folks aren't just cranking out fancy gadgets for showing off....

Continue Reading
Redfin's Strategic Shift as Mortgage Rates Begin to Fall

Updated Category News Views 91

The Mortgage Market and Its Impacts Recent shifts in U.S. mortgage rates have created significant waves in the real estate sector. The 30-year fixed mortgage rate recently hit 7.79%—the highest it’s been since 2000. This surge poses challenges for homeowners, many of whom are hesitant to sell their properties, worried they might sacrifice their favorable lower rates....

Continue Reading